AstraZeneca Plans to Boost Sales to $80 Billion Through Expanded Cancer Drug Portfolio
AstraZeneca’s $80B Sales Plan Leans on Cancer Drug Expansion In a bold move that underscores the pharmaceutical giant’s commitment to consolidating its position at the forefront of cancer treatment, AstraZeneca has unveiled an ambitious sales plan targeting $80 billion by 2030. This strategic pivot places a significant emphasis on the expansion of its cancer drug […]
STAT+: House Panel Invites PBM Executives to Testify.
House Panel Invites PBM Executives to Testify In a significant move that could have far-reaching implications for the pharmaceutical industry and healthcare policy, executives from leading Pharmacy Benefit Managers (PBMs) have been invited to testify before a House panel. The inquiry aims to shed light on the intricate mechanics of drug pricing and the substantial […]
Biotech firm Progentos, supported by Forbion, launches with a $65 million investment for an MS medication.
Forbion-backed Biotech Progentos Debuts with $65M for MS Drug In a significant boost to the field of neurodegenerative diseases, Progentos, a newly formed biotechnology company, has secured an impressive $65 million in initial funding. This financial infusion, spearheaded by the leading European venture capital firm Forbion, positions Progentos at the forefront of developing innovative therapies […]
Eliminating racial adjustment in lung function tests could lead to increased disability benefits for Black veterans.
Impact of Removing Race Adjustment in Lung Function Tests on Disability Payments for Black Veterans In a significant policy shift, the consideration to remove racial adjustments from lung function tests could lead to higher disability payments for Black veterans, addressing a longstanding issue rooted in systemic bias. This move highlights a growing awareness within the […]
Perspective: Audience Feedback on H5N1 and Animal Transport, Ending Insulin Use, and Other Topics.
Opinion: Readers Voice Their Thoughts on H5N1, Insulin Discontinuation, and Other Pressing Issues The pharmaceutical and healthcare industries are bustling with debates and developments that often stir a broad spectrum of opinions. Recently, the topics of H5N1’s impact on livestock movements, the discontinued production of certain insulin types, and more have garnered significant attention. Here, […]
Research on animals bolsters a new approach to HIV vaccination — yet much progress is still needed.
Groundbreaking Progress in HIV Vaccine Development Through Animal Studies The journey toward an effective HIV vaccine has been fraught with both challenges and breakthroughs. In a recent advancement, animal studies have provided promising support to an innovative vaccine strategy that could significantly alter the landscape of HIV prevention. Though optimism is on the rise within […]
FDA sanctions Amgen medication for challenging variant of lung cancer.
FDA Greenlights Amgen’s Pioneering Treatment for Challenging Lung Cancer Variant In a significant advancement for the oncology community, the U.S. Food and Drug Administration (FDA) has officially approved a revolutionary drug developed by Amgen, aimed at a particularly difficult-to-treat form of lung cancer. This groundbreaking therapy, which marks a crucial milestone in the treatment of […]
In the face of criticism towards harm reduction, specialists in addiction caution against reviving the ‘war on drugs’.
Experts Urge Caution in Responding to the Backlash Against Harm Reduction Measures In the ongoing battle against the opioid crisis, harm reduction strategies have emerged as crucial tools in decreasing the consequences associated with drug use. However, recent pushbacks against these measures have alarmed addiction experts, who caution that aggressive backlash could pave the way […]
Investors Inject $400 Million into Licensing Chinese Obesity Medications for Biotech.
A Global Focus on Obesity Management: The $400M Biotech Licensing Deal with China In a landmark move that highlights the escalating global demand for effective obesity treatments, investors have poured an unprecedented $400M into a licensing agreement for novel obesity drugs developed in China. This significant financial infusion underscores the urgency of addressing this worldwide […]
Key Insights for CIOs on the Newly Suggested Rule for Reporting Critical Infrastructure Cyber Incidents.
Understanding the Critical Infrastructure Cyber Incident Reporting Rule: A Guide for CIOs In the ever-evolving landscape of cybersecurity, Chief Information Officers (CIOs) play a crucial role in safeguarding an organization’s digital assets. The recent proposition of the Critical Infrastructure Cyber Incident Reporting Rule marks a significant regulatory development, one that CIOs across industries must understand […]